Wang et al and Raspollini et al reported interesting data in the management of thyroid and uterus leiomyosarcomas through the overexpression of c-Kit proto-oncogene, a tyrosine kinase receptor (4,22). This evidence concerns the gene KIT and leiomyosarcoma.